
Acupuncture,as a typical representative of non-drug therapy,regulates central functions by activating the peripheral nervous system,and has become a leading hotspot in the field of neuromodulation.Focusing on the body-brain mechanism of acupuncture effects,this article systematically reviews the cutting-edge interdisciplinary advancements in acupuncture research and modern life sciences from 3 dimensions:neuro-immune anti-inflammatory actions,target organ function regulation,and"one acupoint affecting multiple organs"intervention for comorbidities.To analyze the key issues,clarify academic viewpoints,and trigger inspirations and discussions,the following are the main points:1)Based on the established understanding that acupuncture stimulation activates autonomic nerve pathways such as the brainstem vagus-adrenal and spinal cord sympathetic-splenic axes,to exert anti-inflammatory effects,it has also been revealed that some vagus nerves can directly traverse and form synaptic connections with catecholaminergic neurons in the celiac ganglion via collateral branches,rather than relay on postsynaptic neurons.It further seeks to clarify the hierarchical relationship among the catecholamine anti-inflammatory,cholinergic anti-inflammatory,sympathetic/parasympathetic nerve pathways,particularly paying attention to the relationship between the concentration-dependent receptor affinity of norepinephrine in the inflammatory microenvironment and its association with acupuncture effects.2)Current researches have demonstrated that acupuncture regulates the homeostasis of the body and internal organs by rebalancing the sympathetic-parasympathetic system at multiple levels,identifying the"off-target"phenomenon caused by the loss of response of tissue cells and receptors under pathological conditions is a key factor affecting the"last mile"of the acupuncture effect.3)Taking the convergence of different visceral input signaling mediated by the intrinsic structures of the spinal cord,as well as the occurrence of comorbidity in the interactive sensitization of the pelvic and sacral organs as an example,results of modern research have provided possible explanations for the cross-segment's and same-segment's"one acupoint affecting multiple organs"and"multiple acupoints affecting one organ"effects of acupuncture.In summary,this article aims to clarify how acupuncture regulates the body's homeostasis through different body-brain autonomic nervous pathways and levels,and offers a review of existing research through 4 dimensions of thinking and inspiration to stimulate new insights and foster exchange of opinions.
Diarrhea-predominant irritable bowel syndrome(IBS-D)is a functional intestinal disorder characterized by recurrent abdominal pain,diarrhea and altered defecation habits.It is frequently comorbid with psychological disorders such as anxiety and depression,which greatly impair the quality of life.Accumulating evidence demonstrates that the core pathological links of IBS-D involve disrupted brain-gut interaction and dysregulation of the brain-gut"neuro-immune axis",including visceral hypersensitivity,low-grade mucosal inflammation,impaired intestinal barrier function,gut microbiota dysbiosis and abnormal autonomic nerve modulation.Zusanli(ST36)is an essential acupoint for digestive disorders,and the ancient maxim"for abdominal-diseases,Zusanli is indicated"summarizes its prominent clinical value in abdominal ailments.Modern studies have verified that acupuncture at ST36 can remodel vagal-sympathetic balance via the peripheral afferent-central integration-autonomic efferent circuit,modulate central nociceptive and emotional processing,and exert regulatory effects on brain-gut peptide signals such as 5-hydroxytryptamine,suppress immune activation and release of inflammatory mediators,improve the expression of tight-junction proteins and intestinal mucosal permeability,as well as modulate microbiota-metabolite-related pathways.Thereby,it attenuates the neuro-immune feedback of"stress-inflammation-pain amplification",alleviates visceral hypersensitivity and relieves symptoms including abdominal pain and diarrhea.Taking the classical maxim"for abdominal-diseases,Zusanli is indicated"as a clue,this paper reviews research advances regarding acupuncture at ST36 in treating IBS-D by regulating the brain-gut"neuro-immune axis".Limitations of current evidence are also pointed out,including insufficient circuit verification,unclear stimulus parameter-effect relationship and non-standardized clinical protocols,so as to provide references for standardized application and mechanistic exploration of acupuncture at ST36 in treating functional gastrointestinal disorders.
OBJECTIVES:To observe the effect of electroacupuncture (EA) at "Zusanli" (ST36) on colonic mucosa injury, expressions of nuclear factor κB (NF-κB), and Aquaporin 8 (AQP8) in 5-fluorouracil (5-FU)-treated mice with transplanted colorectal cancer (CRC), so as to explore its mechanisms underlying improvement of colonic mucosal injury. METHODS:A colorectal cancer cell strain CT26 was subcutaneously injected into BALB/c mice to establish an animal model of transplanted CRC. When the tumor grew to 100-300 mm3, the mice were randomly divided into the tumor-bearing model, chemotherapy, and chemotherapy+EA groups, with 6 mice in each group. Another 6 normal BALB/c mice were used as the normal group. The mice of the chemotherapy group and the chemotherapy+EA group received intraperitoneal injection of 5-FU solution (50 mg/kg, 0.01 mL/g), once daily for 5 d. For mice of the chemotherapy + EA group, EA (2 Hz, 1-2 mA) was applied to bilateral ST36 for 5 min immediately after chemotherapy. During the experiment, the mouse daily Disease Activity Index (DAI) score was determined for assessing the disease severity. The tumor volume was measured once daily. At the end of the experiment, the mice were sacrificed to measure the tumor weight and colonic length. Histopathological changes of the colon tissue were observed after H.E. staining. The serum contents of diamine oxidase (DAO) and D-lactate (D-LA) were detected using ELISA. The immunoactivity of colonic AQP8 was detected using immunohistochemistry, the immunofluorescence intensity of colonic NF-κB was detected using immunofluorescence staining for assessing the nuclear translocation status, and the protein expression levels of colonic NF-κB and AQP8 were detected using Western blot. RESULTS:Compared with the normal group, the tumor-bearing model group had no significant changes in the DAI score, contents of serum DAO and D-LA, immunoactivity, immunofluorescence intensity and protein expression levels of colonic NF-κB and AQP8. In comparison with the tumor-bearing model group, the DAI score in chemotherapy group, and serum DAO and D-LA contents, nuclear translocation and protein expression levels of NF-κB in the chemotherapy group were considerably increased (P<0.05), while the colonic length, tumor volume, tumor weight, and the immunoactivity level of AQP8 were strikingly decreased (P<0.05). Comparison between the chemotherapy and chemotherapy+EA groups showed that the DAI score, serum DAO and D-LA contents, nuclear translocation and protein expression levels of NF-κB in the chemotherapy+EA group were significantly lower than those in the chemotherapy group (P<0.05), while the immunoactivity level of AQP8 in the chemotherapy+EA group was notably higher than that in the chemotherapy group (P<0.05), and no significant differences were found between the chemotherapy and chemotherapy+EA groups in the levels of colonic length, tumor volume and mass. H.E. staining showed that the colonic tissue structure in the tumor-bearing group had no abnormal changes, and that in the chemotherapy group displayed pathological injury, including shortening and thickening of intestinal villi, destruction of glandular structure, increased shedding of goblet cells, infiltration of inflammatory cells, and enlargement of cell nuclei. Compared with the chemotherapy group, the colonic structure in the chemotherapy+EA group was improved, including increase in the villi length, and reduction in the disordered arrangement of the tissue cells and infiltration of inflammatory cells. CONCLUSIONS:EA of ST36 can mitigate intestinal mucosal damage to maintain intestinal barrier function in 5-FU-treated mice with transplanted CRC, which may be related with its functions in inhibiting the excessive activation of the NF-κB signaling pathway, up-regulating the expression levels of AQP8 protein, and reducing DAO and D-LA release.
OBJECTIVES:To investigate the effect of electroacupuncture (EA) on hepatic autophagy in obese mice by regulating the adenosine monophosphate-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR)/unc-51 like autophagy activating kinase 1 (ULK1) signaling pathway. METHODS:C57BL/6J mice were randomly divided into normal group, model group and EA group, with 8 mice in each group. The obese mice model was established by feeding high-fat diet. Mice in the EA group received EA at bilateral "Zusanli"(ST36) and "Tianshu"(ST25) for 30 min, 5 times a week for 4 consecutive weeks. The Lee's index and body mass of mice in each group were observed before and after treatment;fasting serum glucose was measured;the insulin tolerance test (ITT) was performed, and the area under the curve (AUC) was calculated;the levels of fasting insulin, serum low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), and triacylglycerol (TG) were detected by ELISA, and the insulin resistance index was calculated;the mass of mesenteric white adipose tissue (mWAT) and liver tissue was weighed;the morphological changes of mWAT and liver tissue were observed by HE staining;the lipid deposition in the liver tissue was observed by Oil Red O staining;the ultrastructure of liver tissue was observed by transmission electron microscopy;the protein expressions of p-AMPK/AMPK, p-mTOR/mTOR, ULK1, microtubule-associated protein 1 light chain 3 type Ⅱ (LC3- Ⅱ ), autophagy-related 5 (Atg5), autophagy-related 7 (Atg7), and sequestosome 1 (SQSTM1/p62) in liver tissue were detected by Western blot;the mRNA expressions of AMPK, mTOR, ULK1, LC3-Ⅱ, Atg5, Atg7, and p62 in liver tissue were detected by quantitative real-time PCR. RESULTS:Compared with the normal group, the model group showed significant increases in Lee's index, body mass, fasting blood glucose, fasting insulin, insulin resistance index, and ITT-AUC (P<0.01);increased serum TG, TC, and LDL-C levels (P<0.01);decreased serum HDL-C level (P<0.01);increased mWAT and liver mass (P<0.01);enlarged adipocytes with reduced cell number per unit area in mWAT;swollen and disorganized hepatocytes with numerous lipid droplets and vacuoles;extensive orange-red lipid deposition;mitochondrial shrinkage and reduced autophagic vacuoles;decreased AMPK mRNA and p-AMPK/AMPK protein expression (P<0.01);increased mTOR mRNA and p-mTOR/mTOR protein expressions (P<0.01);decreased mRNA and protein expressions of ULK1, LC3-Ⅱ, Atg5, and Atg7 (P<0.01);and increased mRNA and protein expression of p62 (P<0.01). Compared with the model group, the EA group showedsignificant reductions in Lee's index, body mass, fasting blood glucose, fasting insulin, insulin resistance index, and ITT-AUC (P<0.01);decreased serum TG, TC, and LDL-C levels (P<0.01);increased serum HDL-C level (P<0.01);reduced mWAT and liver mass (P<0.01, P<0.05);decreased adipocyte diameter and increased cell number per unit area in mWAT;no obvious lipid droplets or vacuoles in hepatocytes;reduced orange-red lipid deposition;normal mitochondrial structure, increased autophagic vacuoles, and occasional autophagosomes and autolysosomes;increased AMPK mRNA and p-AMPK/AMPK protein expressions (P<0.01);decreased mTOR mRNA and p-mTOR/mTOR protein expressions (P<0.01);increased mRNA and protein expressions of ULK1, LC3-Ⅱ, Atg5, and Atg7 (P<0.01);and decreased mRNA and protein expressions of p62 (P<0.01). CONCLUSIONS:EA at ST36 and ST25 can promote hepatic autophagy in obese mice, and its mechanism may be related to the regulation of the AMPK/mTOR/ULK1 signaling pathway.
Objective:Piper nigrum is a medicinal and edible spice that is popular worldwide due to its unique spicy flavor, and is considered as a folk medicine for treating digestive system diseases. Piperine (PIP) is a bioactive alkaloid derived from P. nigrum, with remarkable hepatoprotective efficacy. Hepatic fibrosis represents a critical phase in the advancement of distinct chronic liver conditions towards cirrhosis, and currently lacks effective therapeutic drugs. The study aims to investigate the hepatoprotective functions of PIP and the underlying mechanism of PIP in combating hepatic fibrosis. Methods:C57BL/6J mice with hepatic fibrosis were induced by thioacetamide (TAA) and subsequently subjected to treatment with PIP or curcumin. Immortalized rat hepatic stellate cells (HSCs) were stimulated with transforming growth factor-β (TGF-β), followed by culture with PIP or niclosamide [signal transducer and activator of transcription 3 (STAT3) inhibitor], respectively. Human hepatic stellate cell line LX-2 were activated by TGF-β and transfected with specific small interfering RNA (siRNA) to silence STAT3 gene, and afterwards cultured with PIP. The mouse AML-12 cells and macrophage-like murine cells Raw 264.7 were stimulated with lipopolysaccharide (LPS), followed by culture with PIP. Results:In vivo, PIP reduced serum transaminase levels, collagen deposition, and decreased the excessive accumulation of extracellular matrix (ECM), comprising α-smooth muscle actin (α-SMA), collagen type I (Collagen I), and tissue inhibitor of metalloproteinases-1 (TIMP-1)/matrix metalloproteinase 13 (MMP13) ratio expressions. PIP inhibited inflammatory cytokines release and myeloperoxidase (MPO) expression, including interleukin-1 receptor type 1 (IL-1R1), cysteine-aspartic acid protease-1 (Caspase-1), and IL-6. PIP specifically inhibited STAT3 phosphorylation at Ser727, downregulated phosphorylated janus kinase 2 (p-JAK2), and upregulated suppressor of cytokine signaling 3 (SOCS3) and protein inhibitor of activated STAT 1/3 (PIAS1/3) expressions. In vitro, PIP inhibited ECM deposition and inflammatory cytokines release in activated HSCs. PIP selectively suppressed p-STAT3 at Ser727 without affecting Tyr705, and modulated p-JAK2, SOCS3, and PIAS1/3 expressions in activated HSCs, function as a STAT3 inhibitor. PIP inhibited LPS‑induced M1 polarization of RAW 264.7 macrophages. PIP decreased Cleaved‑Caspase 3 expression and apoptotic cells in LPS‑induced AML‑12 hepatocytes. STAT3 deficiency amplified regulation of PIP on α-SMA and p-JAK2, as well as its upregulation on SOCS3 and PIAS1/3 in activated LX-2 cells. Conclusion:PIP improved hepatic fibrosis via inhibiting ECM excessive deposition and inflammatory secretion. Switching STAT3 phosphorylation at Ser727 might be the underlying targets for PIP against hepatic fibrosis, which provide an effective candidate and therapeutical strategy for hepatic fibrosis.